ArticleThe International journal on drug policy2020
Safer opioid distribution in response to the COVID-19 pandemic.
Article in The International journal on drug policy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
59 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.
- The health impacts of the COVID-19 pandemic on adults who experience imprisonment globally: A mixed methods systematic review.PloS one · 2022Pooled it
- Non-medical opioid (NMO) use in Canadian adolescents: Trends, risk factors, and regional variations.Canadian journal of public health = Revue canadienne de sante publique · 2026Article
- The association between benzodiazepine proliferation in the unregulated drug supply and experiences of violence: A gender-based analysis.Drug and alcohol dependence · 2026Article
- Harnessing telemedicine to deliver patient-centered opioid agonist treatment within a community-based harm reduction service: a mixed methods evaluation.Harm reduction journal · 2025Article
- Harm reduction self-efficacy and motivations for contactless supply access among a sample of syringe services program participants.Harm reduction journal · 2025Article
- Defining terminology and outcome measures for evaluating overdose response technology: An international Delphi study.Drug and alcohol review · 2025Article
- Unpredictable Drug Access and its Relevance for Substance Use Disorders: A Critical Review.Perspectives on behavior science · 2025Review
- Virtual Primary Care for People With Opioid Use Disorder: Scoping Review of Current Strategies, Benefits, and Challenges.Journal of medical Internet research · 2024Article
- Impacts of the COVID-19 pandemic on the availability and retail price of unregulated drugs in Vancouver, Canada: An interrupted time-series analysis, 2018-2022.The International journal on drug policy · 2024Article
- The cultural turn in understanding 'addiction'.The International journal on drug policy · 2024Article
- Volatile drug use and overdose during the first year of the COVID-19 pandemic in the United States.The International journal on drug policy · 2024Article
- Substance use care innovations during COVID-19: barriers and facilitators to the provision of safer supply at a toronto COVID-19 isolation and recovery site.Harm reduction journal · 2024Article
- Upper Extremity Infection Related to Intravenous Drug Use: Considering the True Cost of the COVID-19 Pandemic and Lockdown.Hand (New York, N.Y.) · 2023Article
- Food insecurity during the COVID-19 pandemic who use drugs in Vancouver, Canada.Public health nutrition · 2023Article
- Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine/naloxone.Journal of substance use and addiction treatment · 2023Article
- Experiences of violence during the COVID-19 pandemic among people who use drugs in a Canadian setting: a gender-based cross-sectional study.BMC public health · 2023Article
- Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2023Article
- "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.BMC public health · 2023Article
- Between Care and Control: Examining Surveillance Practices in Harm Reduction.Contemporary drug problems · 2023Article
- COVID-19-Related Changes to Drug-Selling Networks and Their Effects on People Who Use Illicit Opioids.Journal of studies on alcohol and drugs · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 has turned the world upside down in a very short period of time. The impact of COVID-19 will disproportionately effect people who are least able to protect themselves and this will include people who use drugs. The arrival of the COVID-19 pandemic comes at time when North America is in the midst of a protracted overdose epidemic caused by a toxic illegal drug supply. Overdose deaths are likely to rise when people are isolated, social support programs are cut back, and the illicit drug supply is further compromised. Safer opioid distribution in response to a toxic street drug supply is a pragmatic and effective way to reduce overdose deaths. COVID-19 makes such an approach even more urgent and compelling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.